Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech Ltd has submitted a monthly compliance report to BSE regarding the re-lodgement of physical share transfer requests, as required under a SEBI circular dated July 2, 2025. The company confirmed it ran newspaper advertisements in Financial Express (English) and Nava Telangana (Telugu) on July 15 and September 15, 2025, to inform shareholders about the special window for re-lodging physical share transfers. For the month ended October 31, 2025, the Registrar (Aarthi Consultants Pvt Ltd) reported NIL requests received, processed, approved, or rejected. The report was filed by the Company Secretary on November 5, 2025.
This is a routine regulatory compliance filing with no activity reported for the month — no new transfer requests were received or processed. It has no material impact on shareholders or the stock price.